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Abstract
NutriChem is a database generated by text mining of 21 million MEDLINE abstracts that links
plant-based foods with their small molecule components and human health effect. In this
new, second release of NutriChem (NutriChem 2.0) we have integrated information on over-
lapping protein targets between FDA-approved drugs and small compounds in plant-based
foods, which may have implications on drug pharmacokinetics and pharmacodynamics.
NutriChem 2.0 contains predicted interactions between 428 drugs and 339 foods, supported
by 107 jointly targeted proteins. Chemical bioactivity data were integrated, facilitating the
comparison of activity concentrations between drugs and phytochemicals. In addition, we
have added functionality that allows for user inspection of supporting evidence, the classifica-
tion of food constituents based on KEGG “Phytochemical Compounds”, phytochemical
structure output in SMILES and network output in both static figure and Cytoscape-
compatible xgmml format. The current update of NutriChem moves one step further towards
a more comprehensive assessment of dietary effects on human health and drug treatment.
Database URL: http://sbb.hku.hk/services/NutriChem-2.0/
Introduction
As one of the most dynamic and common environmental
factors, diet can affect human health in a variety of ways
(1–4). Plant-based diet (i.e. fruits and vegetables) is often
regarded as “healthy diet”. To provide a systematic over-
view and to create a platform for the study of the complex
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composition of plant-based foods (referred to as “foods”
below) and their medicinal value, we previously developed
NutriChem 1.0 by text mining of 21 million MEDLINE
abstracts (5). That release of NutriChem contains the
food-compound pairs between 1772 plant-based foods and
7898 phytochemicals, as well as the food-disease associ-
ations between 1066 plant-based foods and 751 diseases.
However, plant-based foods contain a wide range of
phytochemicals that may also interfere with drug pharma-
codynamic and/or pharmacokinetic processes (6, 7). Several
well-known drug–food interactions, either through anec-
dotal experience or scientific research exist. For example,
orange juice is known to decrease the intestinal absorption
of celiprolol, an antihypertensive drug (8); sesame seeds
negatively interfere with tamoxifen affecting the tumor-
inhibitory efficiency of the drug (9); cranberry juice may in-
hibit CYP2C9 activity, the main metabolizing enzyme for
warfarin (10). In addition, many flavonoids including quer-
cetin, catechins and kaempferol were reported to modulate
the absorption and bioavailbility of certain drugs. For ex-
ample, drugs that are P-glycoprotein substrates can be af-
fected by phytochemicals present in plant-based foods such
as green tea and St. John’s wort (11). Drug bioavailability
can also be altered by diet leading to unexpected side effects
and toxicity. Researchers and pharmacists have also catego-
rized the interactions between drugs and general nutrients
into different types, according to the physiological sequence
of drug administration and interaction mechanism (7). As
we have previously demonstrated (12), therapeutic inter-
ventions for most disease classes could be potentially influ-
enced by diet and dietary molecules. An easy-to-access
resource of such interactions could serve as a guideline for
medical doctors about particular foods that should be
avoided under certain medication. Although other efforts
exist, such as DrugBank (13) that describes drug–food
interactions and the associated outcome, where such infor-
mation is available, ignoring the rich natural compound
content inevitably underestimates the magnitude of poten-
tial drug–food interactions.
Here, we present the second release of NutriChem, ac-
cessible at http://sbb.hku.hk/services/NutriChem-2.0. The
major novel feature of the new release is the mapping of
drug–food interactions based on overlapping protein tar-
gets between FDA-approved drugs and plant-based foods,
with the extensive and complex phytochemical content of
foods taken into account. Moreover, we have added func-
tionality to export compound structures in SMILES and
have incorporated compound classifications in the query
outputs. NutriChem-2.0 offers a platform for examining
disease–food and drug–food interactions and supports a
more thorough assessment of dietary influence on human
health and therapy.
Implementation
Data ontologies
Using text-mining of 21 million MEDLINE abstracts, we
previously associated 1772 plant-based foods with their
7898 small molecule components and 1066 foods with
751 human diseases, and integrated them into NutriChem
(5). To infer food–drug interactions, all food–compound
associations from NutriChem-1.0 were used. FDA-
approved small-molecule drugs and drug names were
retrieved from DrugBank V4.5.0 (13). Drugs were mapped
to indicated diseases and disease classes using the
Therapeutic Target Database (TTD) (14) and the Disease
Ontology (DO) database (15), with “disease class” based
on the third level of disease hierarchy in DO.
Drug–food interaction data
Both drug–protein and dietary compound–protein inter-
actions were retrieved as previously described (12), further
expanded to include ChEMBL (16) bioactivity values of
Ki, Kd, IC50 and EC50. The ChEMBL-normalized values
(pChEMBL, i.e. negative log10 transformation) of such
bioactivities were used to facilitate comparisons and inte-
gration of different measurement types. A dietary com-
pound–protein interaction was included only if the binding
bioactivity was up to 20% lower than the minimum bio-
activity of drugs targeting the same protein. For example,
for a target with drug bioactivity values in the range 3–4
mM, we have included all food compound bioactivities up
to 4.8 mM. The interactions between FDA-approved drugs
and plant-based foods were created, on the basis of over-
lapping interacting protein partners between drugs and
food compounds (Figure 1), as well as the food-compound
associations from NutriChem-1.0. Disease annotations to
drug-food interactions were retrieved, when available,
from TTD, in contrast with our previous work, where dis-
ease names were mapped from drug protein targets (12).
According to the disease hierarchy in DO, we further asso-
ciated drug–food interactions to a disease class, such as
cancer and cardiovascular.
Other updates in NutriChem-2.0
Apart from the novel drug-food interaction section, we
also updated several aspects in “plant–compound search”.
We made phytochemical structures downloadable in
SMILES format (at the bottom-right corner after searches
by foods with “Food-Disease Associations” selected),
allowing users to perform a range of chemoinformatics
analyses including, but not limited to, structural similarity
comparisons and cross-reference to other databases.
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To facilitate a better characterization of food constituents,
we added hierarchical compound classification informa-
tion based on KEGG “Phytochemical Compounds” (http://
www.genome.jp/kegg-bin/get_htext?br08003.keg).
Examples include flavonols and flavones that belong to fla-
vonoids, as well as carotenoids categorized into terpenoids.
Such information is now available when users query a food
in “Food-Disease Association” section of NutriChem.
Database description
In addition to the data already incorporated in
NutriChem-1.0, the new NutriChem-2.0 includes 14 662
drug–food interactions covering 107 proteins jointly tar-
geted by 428 drugs and 339 foods. It further categorizes
drug–food interactions in 59 diseases and 19 general dis-
ease classes, among which nervous, cardiovascular and
musculoskeletal system diseases appear to be the most vul-
nerable to drug-food interactions.
The “Food Interactions” section in DrugBank for the anti-
coagulant drug warfarin has the following information:
“Avoid St. John’s Wort”; “Consult your doctor before ingest-
ing large amounts of dietary Vitamin K (e.g. from green leafy
vegetables)”; “Limit garlic, ginger, gingko and horse chest-
nut” (http://www.drugbank.ca/drugs/DB00682). NutriChem
2.0 zooms at the molecular layer of the aforementioned inter-
action and supports the anecdotal knowledge with literature
evidence for two jointly targeted proteins (P02768 and
P11712) between warfarin and multiple bioactive com-
pounds in St John’s wort (e.g. kaempferol); parsley (whose
interaction with warfarin has also been reported previously)
(10) and ginkgo (Ginkgo biloba) also appear in the list of
warfarin-interacting foods with appropriate molecular-based
support.
The homepage of NutriChem-2.0 has been designed to
accommodate searches by food, disease, compound or
drug. A detailed instruction on NutriChem-2.0 usage is
available on the server. Users can choose among one of the
following two query options:
1. The updated “Food-Disease Associations” section that
contains all the functionality of NutriChem-1.0 accepts
food, disease and compound queries and returns plant–
disease associations and/or plant–compound associ-
ations. In addition, it provides experimental data on
phytochemical–protein interactions and predicted com-
pound–disease associations. This section links the
chemical space of plant-based foods with human dis-
ease phenotypes and offers a platform to explore the
medicinal value of foods.
2. The new “Drug-Food Interactions” query serves as the
major update, as described in detail below. It accepts
three types of queries as input (Figure 1): (a) drug query,
where a drug name or DrugBank ID may be used; (b)
food query, using a plant-based food name or correspond-
ing NCBI Taxonomy ID; (c) disease query, where users
may either provide a disease name (or corresponding IDs
in Disease Ontology database) or select a disease class
name. To the best of our knowledge, this release of
NutriChem is the first resource for performing such food-
centric search of drug–food interactions. Before submit-
ting a query, the user has the option to define the number
of jointly targeted proteins required for an edge (i.e. one
drug–food interaction pair) and the number of edges
allowed to a node in the generated CytoScapeWeb net-
work (http://cytoscapeweb.cytoscape.org). By default, we
use a minimum of one protein for an edge (ranging from
1 to 10) and a maximum of 15 edges for a node (ranging
from 5 to “All edges”). The threshold on proteins applies
to both network visualization and result table, while the
limit on number of edges applies only to the network. It
is, however, not recommended to show all edges because
this will consume system resources, when massive amount
of data are returned. A default search returns all retrieved
drug–food interactions, as well as the number of proteins
jointly targeted by the drug and the phytochemicals. The
user can zoom in the interactions involving specific drug-
interacting protein types (drug targets, enzymes, trans-
porters and carriers) or return to the homepage and sub-
mit a new query. The drug–food interactions affecting
drug targets may interfere with drug pharmacodynamics,
while those involving enzymes, transporters and carriers
can influence the pharmacokinetic process.
Case study
Ketoprofen (DrugBank ID: DB01009) is a drug indicated
for rheumatoid arthritis, osteoarthritis and alleviation of
Figure 1. The flowchart of the “Drug–Food Interactions” section of
NutriChem-2.0 and the three different query options (drugs, foods and
disease).
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moderate pain. Using it to query the “Drug–Food
Interaction” section of NutriChem returns, by default, a
list of 61 unique plant-based foods (ordered by the number
of jointly targeted proteins) that may affect its efficacy
(bottom right, Figure 2). The summary section (top right)
of the web page shows that 14 (23%) of them appear to
contain compounds that exhibit biological activity against
two disease-relevant proteins. Clicking on the “Drug
Target Interactions” button at the top displays 61 foods,
where the drug–food interactions are based on overlapping
“drug targets”. Notably, most of them are found to affect
pharmacodynamics by interfering with Ketoprofen targets
such as prostaglandin G/H synthase 1 (P23219) and pros-
taglandin G/H synthase 2 (P35354), whereas almost no
interactions are related to drug pharmacokinetics, with the
exception of one interaction between narrowleaf cattail
(Typha angustifolia) and the drug transporter solute carrier
family 22 member 6 (Q4U2R8). Clicking on one drug–
food pair in the table or one particular edge in the network
will display detailed information, including drug names,
protein targets, types of protein targets, drug–target bio-
activity range, food names, the numbers and names of
plant compounds for each food–protein interaction.
Within the network, the edge width reflects the number of
proteins for each drug-food pair. The size of food node re-
flects the total number of interaction pairs between com-
pounds in the involved food and protein targets jointly
targeted with Ketoprofen. If desired, users may also ma-
nipulate the network or zoom in and out using the
toolbox.
Black tea has two overlapping protein targets with
Ketoprofen and clicking on this pair reveals a total of 5
phytochemical–protein interactions, as also indicated by
the medium node size in the network (Figure 2). The user
may click on the target, drug or food name, in order to be
redirected to UniProt, DrugBank and NCBI Taxonomy
Browser, respectively. Moreover, clicking on the “Number
of Compounds” field will show the phytochemicals (i.e.
epigallocatechin and apigenin in Black tea) responsible for
the underlying biological activity, and, hence, for the po-
tential drug–food interaction, as well as PubMed evidence
for the food–compound association, their ChEMBL com-
pound records, the compound–target bioactivities and the
option to export compound structures in SMILES format
(bottom-right corner of web page). The full output list and
the network are downloadable using the “Export table”
and “Export network” (as PDF or XGMML) button
(Figure 2), which can be opened and edited using text edi-
tor, image processor (for PDF) or Cytoscape (17) (for
XGMML), respectively.
Querying for rheumatoid arthritis (or “DOID:
7148”)—the disease indication of Ketoprofen—in the
“search by disease” field and selecting “Drug–Food
Interactions” takes the user to an extensive collection of
disease-specific drug–food interactions, covering seven dif-
ferent drugs, including Ketoprofen (Figure 3). In the results
table, the different drugs are listed with corresponding
drug-food interactions ordered by the number of proteins.
For clarity in network visualization, only the drug with the
highest number of interacting foods (Leflunomide in this
Figure 2. The example output page when using the drug Ketoprofen as a query of Drug–Food Interaction section.
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case) is shown by default, together with the foods that it
potentially interacts with. Users may switch to the network
for another drug of interest, using the dropdown menu at
the upper-left corner (Figure 3). Some plant-based foods or
herbs, for example ginkgo, black tea and Japanese honey-
suckle (Lonicera japonica), are found to potentially inter-
fere with the pharmacological properties of all seven drugs.
Last but not least, selecting as query the general disease
class “Musculoskeletal System Disease” that rheumatoid
arthritis belongs to, returns in total interactions between
16 drugs and 174 plant-based foods.
Conclusion
Although sporadic information on drug–food interactions
has been deposited in databases such as DrugBank (13),
clinical management of most interactions are largely based
on anecdotal experience and uncontrolled observations
(7). There is still a lack of systematic and molecular-level
collection and prediction of such data. In NutriChem-2.0
database, we incorporated information on overlapping tar-
gets between drugs and food constituents that may have
implications on drug pharmacodynamic and pharmacoki-
netic process. This update of NutriChem, integrating all to-
gether diet–drug–disease interactions, moves one step
further towards a more comprehensive assessment of diet-
ary effects on human health and drug treatment.
Pharmacists and nutritionists can access such interactions
easily and take actions accordingly. Having said that, we
should bear in mind that experimental evidence of a drug
and a phytochemical sharing a protein target is not a proof
for the presence of a drug–food interaction but rather con-
sists an indication that should be further established via ex-
perimental and clinical validations. In line with this, the
incorporation of confidence scores based on the availabil-
ity of support from literature or patient records may serve
as future update of NutriChem.
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